|
| |
Image Results
Loading...
Loading...
Immunogen Patents Pages on BioPortfolio:
BioPortfolio - ImmunoGen - Profile
7 Jul 2009 ... ImmunoGen Patents: • 6441163- Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents ...
http://www.bioportfolio.com/biocorporate/5298-ImmunoGen.pdf...
|
Biotechnology News Search
Medical News: ImmunoGen, Inc. Announces Encouraging Clinical Data With Its IMGN901 ... in technology, patents, and products for motion-sensing applications
, ...
http://www.bioportfolio.co.uk/Biotechnology_News_from_BioFin...
|
BioInvent Issued US Patent for n-CoDeR Antibody Library
11 Jan 2006 ... BioInvent has already obtained corresponding patents in Europe, ... Antisoma, Celltech, GlaxoSmithKline, Igeneon, ImmunoGen, OrbusNeich, ...
http://www.bioportfolio.com/biotech_news/BioInvent_5.htm...
|
|
BioPortfolio Biotechnology BioNews : live article
By contrast, Teva fell after losing a ruling in a patent dispute. ... Also sliding was Immunogen IMGN, down 46 cents, or 8.13 percent, ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=h...
|
BioPortfolio - CXCR7 - chemokine (C-X-C motif) receptor 7
Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic ... Patents logo. US Patent No. Title. 7598028, Compositions and methods for ...
http://www.bioportfolio.com/gene/57007-CXCR7.html...
|
BioPortfolio - Aphton Corporation
Aphton Corporation Patents: US Patent No. Title. 6861510, Immunogenic compositions against gastrin peptides. 4814170, Method for immunization against
and ...
http://www.bioportfolio.com/biocorporate/395-Aphton_Corporat...
|
BioPortfolio - Solvo Biotechnology
SOLVO Biotechnology owns a substantial patent portfolio relating to drug targets and ... in the area of biotechnology business reported from ImmunoGen, Inc. ...
http://www.bioportfolio.com/biocorporate/9649-Solvo+Biotechn...
|
BioPortfolio - United Biomedical Inc - Profile
6811782- Peptide composition as immunogen for the treatment of allergy ... information resources: publications, clinical trials, patents and global news.
...
http://www.bioportfolio.com/biocorporate/10466-United+Biomed...
|
BioPortfolio - Solvo Biotechnology - Profile
... in the area of biotechnology business reported from ImmunoGen, Inc. ... information resources: publications, clinical trials, patents and global news.
...
http://www.bioportfolio.com/biocorporate/9649-Solvo+Biotechn...
|
BioPortfolio - the biotechnology, pharmaceutical, life science and ...
19 Nov 2009 ... ImmunoGen Nabs $1M From Amgen Xconomy Nov 19 2009 11:03PM ... publications, patents, clinical trials, news eg Sarcoma, Lymphocytes ...
http://www.bioportfolio.com/index.shtml...
| Results from other life science and pharmaceutical sites:
Technology evaluation: C242-DM1, ImmunoGen Inc.
EP-00425235, held by ImmunoGen, covers conjugated forms of ansamitocin ( maytansine) derivatives. Takeda holds several patents for the production of ...
http://www.ncbi.nlm.nih.gov/pubmed/11338934...
|
News: ImmunoGen, Inc. Announces Presentations at the AACR-NCI ...
10 Nov 2009 ... ImmunoGen, Inc. (Nasdaq: IMGN), a biopharmaceutical company that develops ... New Recommendations for Gene Patents - Thank Goodness! ...
http://www.genengnews.com/news/bnitem.aspx?name=68048964&tax...
|
Adjuvants and delivery issues related to immunization: a survey of ...
Such a rational approach to immunogen design results in what has been termed ... In this editorial, I review the recent patent literature as it pertains to ...
http://www.ncbi.nlm.nih.gov/pubmed/9894692...
|
Anti-TrkB ln pAb Product Information Sheet, 9pig156
Immunogen: The immunogen is a fusion protein generated in E. coli using a proprietary technology ... patents or may have certain limitations. Please visit
...
http://www.promega.com/techserv/tools/abasst/AntibodyPages/p...
|
Evaluation of the effects of a new drug candidate (GEMSP) in a ...
19 May 2008 ... GEMSP was synthesized according to patent numbers 6114388 (USA) and ..... is a non-immunogenic peptide (see patent numbers of GEMSP: 6114388 ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=24...
|
Office of Patents and Licensing Biomarkers and Diagnostics
predominant immunogen in ulcerative colitis patients. UC is difficult to diagnose because .... contact Judith Ladd at the Office of Patents and Licensing
. ...
http://www.umdnj.edu/resrhweb/patents/for_licensing/diagnost...
|
SUNY honors UB faculty members - UB Reporter
SUNY patents generated $17.6 million in royalties in fiscal 2002. ... This vaccine candidate can be used as an immunogen in vaccine formations against E.
...
http://www.buffalo.edu/reporter/vol34/vol34n25/articles/rese...
|
CURRICULUM VITAE Christopher C. Broder, Ph.D.
Oligomeric HIV-1 Envelope Glycoproteins (gp140): U.S. Patent Nos. 6039957; 6171596. Methods for Production,. Purification, and Use as an Immunogen in ...
http://www.usuhs.mil/mic/broder_CV.pdf...
|
Wiskott Aldrich syndrome - NIH Office of Technology Transfer (OTT)
Vaccine candidates have included a variety of HIV immunogens delivered as DNA, .... The patents and patent applications describe a group of novel compounds ...
http://ott.od.nih.gov/Technologies/RareDiseases.aspx?RareDis...
|
Comp CX045 SM-TCTP
Allergic response. Histamine release. Stage of Development. Purified antibody and immunogen available. Patent Status. Status. Seeking Licensing or ...
http://uic.edu/depts/ovcr/research/techtransfer/available_te...
|
|
